Abstract

This study investigates the bladder from patients with recurrent urinary tract infection (rUTI) at baseline and after intravesical platelet-rich plasma (PRP) injections. Patients with rUTI who underwent repeated intravesical PRP injections provided bladder and urine specimens at baseline and after treatment. Bladder specimens were investigated with electron microscopy and Western blotting. The urine sample was analyzed with commercially available Milliplex immunoassays. A total of 29 patients were enrolled. At baseline, the rUTI bladders exhibited defects of integrity in umbrella cells, a widened tight junction, and lysed organelles. Intracellular bacterial community incubations in the epithelial cells were also noted. Improvement in bladder defects after PRP injection was noted in 25–42% of patients. Bladder UPK3 expression was significantly lower in the patients with rUTI than in controls. Baseline levels of urinary inflammatory cytokine interleukin (IL)-6, IL-8, and brain-derived neurotrophic factor were higher in the patients with rUTI than in the controls, but there were lower levels of vascular endothelial growth factor and nerve growth factor. In the patients with rUTI who recovered from acute infection, the bladders still had immature urothelium, various ultrastructural defects, and elevated urinary inflammatory cytokines. PRP injection has the potential to promote bladder recovery in some of these patients.

Highlights

  • Urinary tract infection (UTI) is one of the most common diseases in both urology and the local primary care clinic [1]

  • We previously reported decreased E-cadherin and increased apoptotic cells in the bladder urothelium in patients with recurrent urinary tract infection (rUTI) [6], providing evidence to support a defect in the bladder defense mechanism in human rUTI

  • Cystoscopy during the procedure did not show any significant abnormality in patients with rUTI, and 17 patients (14 successful and 3 unsuccessful outcomes) agreed to provide bladder specimens at the first and fourth Platelet-rich plasma (PRP) injections

Read more

Summary

Introduction

Urinary tract infection (UTI) is one of the most common diseases in both urology and the local primary care clinic [1]. The pathogenesis of rUTI in humans involves bacterial factors and deficiencies in host defense [4]. We previously reported decreased E-cadherin and increased apoptotic cells in the bladder urothelium in patients with rUTI [6], providing evidence to support a defect in the bladder defense mechanism in human rUTI. Platelet-rich plasma (PRP) injection has been used to treat inflammatory diseases in clinical practice [8,9], and a preclinical study provided evidence to show that the hepatocyte growth factor in PRP mediated the antiinflammatory effect [10].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call